Back

Ticagrelor- and prasugrel-mediated platelet inhibition is not affected by mild therapeutic hypothermia generated in vitro in patients with an acute myocardial infarction

28 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Best Posters 5 - Best Posters in antiplatelet agents in acute coronary syndromes Thrombosis and platelets ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Irene Buera Surribas

University Hospital Vall d'Hebron, Barcelona (Spain)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Professor E. Navarese (Sassari, IT)
Presentation thumbnail
Assistant Professor J. Choe (Pusan, KR)
Abstract Slides
Presentation thumbnail
Professor Y. Jeong (Gwangmyeong, KR)
Abstract Slides

Access the full session

Session thumbnail
Best Posters 5 - Best Posters in antiplatelet agents in acute coronary syndromes

The Event

Event poster

ESC Congress 2017

28 August 2017 14:00 CET
You may be interested in
thumbnail
Congress Session
State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?
14 March 2025
thumbnail
Congress Presentation
STEMI patients after out-of-hospital cardiac arrest: should we cool?
27 August 2023
thumbnail
Congress Presentation
Platelet inhibitory profiles of prasugrel versus ticagrelor in patients with CYP2C19 loss-of-function genotypes undergoing percutaneous coronary intervention: results of a randomized feasibility study
1 September 2019
thumbnail
Congress Presentation
Efficacy and safety of cangrelor on top of anticoagulation in patients with myocardial infarction related cardiogenic shock or cardiac arrest receiving va ecmo: preliminary data from a phase 2 trial
20 February 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources